These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9972400)

  • 1. Clinical significance of falsely elevated vancomycin concentrations in end-stage renal disease.
    Kim JS; Perkins RJ; Briceland LL; Tobin EH
    Ann Pharmacother; 1999 Jan; 33(1):116-8. PubMed ID: 9972400
    [No Abstract]   [Full Text] [Related]  

  • 2. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL; Mueller BA; Scott MK; Carfagna MA; Kraus MA
    Am J Kidney Dis; 1996 Jan; 27(1):67-74. PubMed ID: 8546140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin therapy for serious staphylococcal infections in chronic hemodialysis patients.
    Bierman MH; Needham-Walker CA; Hammeke M; Egan JD
    J Dial; 1980; 4(4):179-84. PubMed ID: 7204716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with vancomycin fluorescence polarisation immunoassay in a nonuraemic patient.
    Bowhay S; Timms P
    Ther Drug Monit; 1997 Feb; 19(1):117-9. PubMed ID: 9029761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure.
    Najjar TA; al-Dhuwailie AA; Tekle A
    J Chromatogr B Biomed Appl; 1995 Oct; 672(2):295-9. PubMed ID: 8581137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V; Verbeelen D; Maes V; Sennesael J
    Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged elevation of vancomycin concentrations in a patient with end-stage renal disease.
    Amodio MI; Monane M; Klein RS
    South Med J; 1990 Jan; 83(1):77-8. PubMed ID: 2300843
    [No Abstract]   [Full Text] [Related]  

  • 9. Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease.
    Somerville AL; Wright DH; Rotschafer JC
    Pharmacotherapy; 1999 Jun; 19(6):702-7. PubMed ID: 10391415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More information on vancomycin clearance by new hemodialysis membranes.
    Mueller BA; Scott MK; Clark WR
    Am J Health Syst Pharm; 1996 Jun; 53(11):1339-40, 1348. PubMed ID: 8725212
    [No Abstract]   [Full Text] [Related]  

  • 11. Accuracy of measured vancomycin serum concentrations in patients with end-stage renal disease.
    Smith PF; Morse GD
    Ann Pharmacother; 1999 Dec; 33(12):1329-35. PubMed ID: 10630833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Falsely elevated serum vancomycin concentrations.
    Sztukowski B
    Am J Kidney Dis; 1996 Jul; 28(1):158. PubMed ID: 8712216
    [No Abstract]   [Full Text] [Related]  

  • 13. Infective endocarditis: a frequent disease in dialysis patients.
    Hoen B
    Nephrol Dial Transplant; 2004 Jun; 19(6):1360-2. PubMed ID: 15004259
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of vancomycin by fluorescence polarisation immunoassay and EMIT in patients with renal failure.
    Saunders NJ; Want SV; Adams DJ
    J Antimicrob Chemother; 1995 Aug; 36(2):411-5. PubMed ID: 8522471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis.
    Eykyn S; Phillips I; Evans J
    Br Med J; 1970 Jul; 3(5714):80-2. PubMed ID: 5428782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent changes in vancomycin use in renal failure.
    Vandecasteele SJ; De Vriese AS
    Kidney Int; 2010 May; 77(9):760-4. PubMed ID: 20182415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
    Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin monitoring in term newborns: comparison of peak and trough serum concentrations determined by high performance liquid chromatography and fluorescence polarization immunoassay.
    Feferbaum R; Kobol Machado JK; de Albuquerque Diniz EM; Okay TS; Santos SR; Ceccon ME; Krebs VL; de Araújo MC; Costa Vaz A
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(5):149-52. PubMed ID: 11781595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum.
    Ackerman BH; Berg HG; Strate RG; Rotschafer JC
    J Clin Microbiol; 1983 Oct; 18(4):994-5. PubMed ID: 6630478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.